Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index.
Abstract
Despite some significant advancements, breast cancer has become the most prevalent cancer in the world. One of the main reasons for failure in treatment and metastasis has been attributed to the presence of cancer initiating cells-cancer stem cells. Consequently, research is now being focussed on targeting cancer cells along with their stem cell population. Non-oncology drugs are gaining increasing attention for their potent anticancer activities. Metformin, a drug commonly used to treat type 2 diabetes, is the best example in this regard. It exerts its therapeutic action by activating 5' adenosine monophosphate-activated protein kinase (AMPK). Activated AMPK subsequently phosphorylates and targets several cellular pathways involved in cell growth and proliferation and the maintenance of stem-like properties of cancer stem cells. Therefore, AMPK is emerging as a target of choice for developing effective anticancer drugs. Vanadium compounds are well-known PTP inhibitors and AMPK activators. They find extensive applications in treatment of diabetes and obesity via PTP1B inhibition and AMPK-mediated inhibition of adipogenesis. However, their role in targeting cancer stem cells has not been explored yet. This review is an attempt to establish the applications of insulin mimetic vanadium compounds for the treatment of breast cancer by AMPK activation and PTP1B inhibition pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, activated AMPK phosphorylates and disarms key components of pathways involved in cell growth and maintenance of cancer cell stemness, thus constituting a potential target of anticancer drugs.228”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [228]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, H., Park, H. J., Park, C., Oh, E., Choi, B.-H., Williams, B. W., Lee, C. K. K., & Song, C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087979 · Cited by 97 · cited 1×
“AMPK activation by metformin also involves downregulation of mTOR for the anticancer effect [91,92].”
BackgroundRetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 3×
“They discovered that as few as 100 of these cells were potent enough to form tumours when xenotransplanted in mice [5].”
BackgroundThe Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · cited 1×
“Activated AMPK suppresses mTOR by phosphorylating and activating the tuberous sclerosis complex (TSC) that negatively regulates mTOR signalling [23,89,90].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Many independent systematic studies reported lower risk and occurrences of cancer in diabetic patients on metformin treatment [21,22].”
BackgroundZhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 1×
“Therefore, BCSCs are fundamentally more resistant to the currently employed clinical techniques (chemo and radiation) [5,9].”
BackgroundTargeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
The role of AMPK in macrophage metabolism, function and polarisation
Cui, Y., Chen, J., Zhang, Z., Shi, H., Sun, W., & Yi, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04772-6 · Cited by 185
Targeting Breast Cancer: An Overlook on Current Strategies
Iacopetta, D., Ceramella, J., Baldino, N., Sinicropi, M., & Catalano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043643 · Cited by 88
Wang, J., Shao, F., Yu, Q., Ye, L., Wusiman, D., Wu, R., Tuo, Z., Wang, Z., Li, D., Cho, W. C. S., et al. (2025) · Research · doi:10.34133/research.0612 · Cited by 72
“Upon activation, AMPK triggers several pathways to restore energy balance, such as promoting glucose uptake and fatty acid oxidation while inhibiting energy-consuming processes like protein synthesis [ 2 , 292 ].”
Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer
Sousa‐Coelho, A. L. D., Fraqueza, G., & Aureliano, M. (2023) · Pharmaceuticals · doi:10.3390/ph17010012 · Cited by 39
“Involved pathways for vanadium compounds may include AMP-activated protein kinase (AMPK) activation and protein tyrosine phosphatase 1B (PTP1B) inhibition pathways, as described for the treatment of breast cancer [26].”
BackgroundMallardo, D., Simeone, E., Vanella, V., Vitale, M. G., Palla, M., Scarpato, L., Paone, M., Cristofaro, T. D., Borzillo, V., Cortellini, A., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03643-w · Cited by 24
Berberine: Potential preventive and therapeutic strategies for human colorectal cancer
Feng, Y., Lu, J., Jiang, J., Wang, M., Guo, K., & Lin, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4033 · Cited by 24
“125 While BBR prevents colonic epithelial proliferation through AMPK ‐ dependent inhibition of mTOR activity.”
BackgroundMalla, R. R., Jyosthsna, K., Rani, G., & Nagaraju, G. P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112613 · Cited by 25
The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention
Albini, A., Noonan, D. M., Corradino, P., Magnoni, F., & Corso, G. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-24-0085 · Cited by 25
Zhuravleva, O. I., Belousova, E. B., Oleinikova, G. K., Antonov, A. S., Khudyakova, Y. V., Rasin, A. B., Popov, R. S., Menchinskaya, E. S., Trinh, P. T. H., Yurchenko, A. N., et al. (2022) · Marine Drugs · doi:10.3390/md20090584 · Cited by 19
Maharajan, N., Benyamien-Roufaeil, D. S., Brown, R. A., Portney, B. A., Banerjee, A., & Zalzman, M. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218015 · Cited by 20
Khaliq, H. A., Alhouayek, M., Quetin‐Leclercq, J., & Muccioli, G. G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2145264 · Cited by 17
“…to the diseases discussed in previous sections, inflammation is also one of the main contributing factors of other diseases such as nonalcoholic fatty liver disease (NAFLD), obesity, diabetes, and cancer (previously reviewed in (Ponnusamy et al. 2020; Uprety and Abrahamse 2022; Hsu et al. 2022)).”
BackgroundLai, I., Liao, C.-H., Hu, M., Chang, C., Lai, G., Chiou, T.-J., Hsia, S., Tsai, W., Lin, Y.-Y., Chuang, S., et al. (2022) · Nutrients · doi:10.3390/nu14153232 · Cited by 12
SOLID LIPID NANOPARTICLES: A REVIEW ON DIFFERENT TECHNIQUES AND APPROACHES TO TREAT BREAST CANCER
Gajbhiye, S. A., & Patil, M. P. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i2.46970 · Cited by 12
Aydın, S., Tekinalp, S. G., Tuzcu, B., Çam, F., Sevik, M. O., Tatar, E., Kalaskar, D. M., & Çam, M. E. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100577 · Cited by 14
CircWHSC1 (CircNSD2): A Novel Circular RNA in Multiple Cancers
Zhang, X., Yuan, Y., Wang, X., Wang, H., Zhang, L., & He, J. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241254781 · Cited by 8
“96,97 This study also revealed that inhibiting FASN or activating AMPK can increase the expression of apoptosis-related proteins, including Bax, c-Caspase3, and E-cadherin.”
BackgroundHashemi, M., Razzazan, M., Bagheri, M., Asadi, S., Jamali, B., Khalafi, M., Azimi, A., Rad, S., Behroozaghdam, M., Nabavi, N., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154849 · Cited by 6
Jiang, T., Wang, J., Xie, L., Zhou, S., Huang, Y., Chen, Y., Gao, X., Xiao, W., & Chen, J. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.017 · Cited by 6
Deciphering the critical roles of the AMPK/mTOR signaling pathway in cancer cell metabolism (Review)
Alasadi, A., Fadhil, N. M., & Chen, S. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.391 · Cited by 9
“In breast cancer, AMPK displays perhaps the most well‑known dual roles, with its function determined mainly by tumor stage, phenotype and microenvironmental situ‑ ations (178).”
Afzal, I., Zeb, A., Mazhar, D., Khan, J., Altaf, S., Ain, Q., & Ali, H. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106711 · Cited by 4
Hjazi, A. M., Mohammed, S. N., Abosaoda, M. K., Ahmad, I., Rekha, M. M., Kundlas, M., Ullah, M. I., Abd, B., Ray, S., & Nathiya, D. (2025) · Medical Oncology · doi:10.1007/s12032-025-02907-x · Cited by 3
“In breast cancer, activating AMPK can slow tumor growth and inhibit metastasis [97, 98].”
New Insights into the Basic and Translational Aspects of AMPK Signaling
Ladilov, Y. V., & Aslam, M. (2023) · Cells · doi:10.3390/cells12020206 · Cited by 2
Zhen, S., Huang, L., Zhu, Q., Chen, R., Wang, J., & Zha, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618193 · Cited by 1
“Despite substantial evidence linking TMM and stem cells to BC pathogenesis, the precise molecular pathways mediating their effects remain incompletely elucidated (28).”
Tang, T., Li, M., Yuan, M., Li, Y., Wang, C., Zhong, Q., Zhang, X., Huang, Y., Tao, F., Su, P., et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122276 · Cited by 1
Phenformin Inhibits the Proliferation of MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines
SEN, A. H., Çetinavcı, D., Yiğittürk, G., Yazici, A. E., Elbe, H., & Öztürk, F. (2023) · Medical Records · doi:10.37990/medr.1137136
Zhan, Z., Cheng, J., Liu, F., Tao, S., Wang, L., Lin, X., & Ye, Y. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae159
Research Progress of Metformin in the Treatment of Breast Cancer
李, 雪. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153608
Kim, G.-H., Lee, J., Chung, K., Seo, K.-B., Hong, J.-W., Yun, S.-J., Lee, J. Y., & Lee, K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123983
Breast cancer stem cell targeting
Khanra, S., Kothandan, S., Pachiyappan, J. K., Paul, P., Singh, P. K., Selvaraj, K., & Kuppusamy, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33349-1.00009-0
Yanardağ, R., Ertik, O., Bal‐Demirci, T., Ülküseven, B., & Tunalı, S. (2025) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.1734840
Mallardo, D., Simeone, E., Vanella, V., Vitale, M. G., Palla, M., Scarpato, L., Paone, M., Cristofaro, T. D., Borzillo, V., Cortellini, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21256984
Ennis, C. S., Huang, K., Casey, A. N., Seen, M., & Denis, G. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701869
AMPK as a central node in cancer and cardiovascular diseases
Long, Y., Li, Z., & Ou, W. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179300
Metadata
- Authors
- Uprety, B., & Abrahamse, H.
- Affiliations
- University of Johannesburg (ZA)
- Corresponding author
- Uprety, Bhawna
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-02-07
- Volume
- 11
- Issue
- 3
- Pages
- 576
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8834477
- OpenAlex
- W4210907560
- Cited by
- 33
- References
- 189
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 5
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (98337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Physical Sciences › Chemistry › Inorganic Chemistry › Vanadium and Halogenation Chemistry
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer, cancer stem cells, AMPK activation, metformin, vanadium compounds, PTP1B inhibition, insulin mimetics, anticancer drug targets, stem cell-like properties
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplastic Stem Cells, Vanadium Compounds, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.